University of Kentucky USA
Mark R Rigby,,
Indiana University USA
Pedro A. Jose,,
The George Washington University USA
Tahira I. Lodhi,,
Goerge Washington University USA
Dharambir K Sanghera,,
University of Oklahoma Health Sciences Center USA
Yong Fu Xiao,,
Crown Bio Science Inc USA
National Polytechnic Institute Mexico
Yochai Birnbaum ,,
Cardiology Research and Education Baylor College of Medicine USA
Recommended Global Diabetes & Endocrinology Webinars & Conferences
Europe & UK
Asia Pacific & Middle East
Euro Diabetes 2024
Welcome to the Euro Diabetes 2024 Conference
With the amalgamation of peerless speakers of Diabetes 2024, Conference Series LLC Ltd is privileged to announce its “33rd European Diabetes Congress” which will be held during February 08-09, 2024 Paris, France. We cordially welcome all the eminent researchers, students and delegates to take part in this upcoming Diabetes congress to witness invaluable scientific discussions and contribute to the future innovations in the field of Diabetes.
Euro Diabetes 2024 will focus on the latest and exciting innovations in all areas of Diabetes research which offers a unique opportunity for investigators across the globe to meet, network, and perceive new scientific innovations. This year’s annual congress highlights the theme, “Empowering Lives: Managing Diabetes Together” which reflects the innovative progress in Diabetes disease research. The two days conference includes workshops, symposiums, special keynote sessions conducted by eminent and renowned speakers who excel in the field of Diabetes which include: Physiology & Anatomy of Diabetes, Clinical Research and Case Study: Diabetes, Diabetes prevention and management, Diabetes complication & disorder in children, teens, adolescence, Emerging focus in Diabetes research, Diagnostic approaches of Diabetes, Diabetes & Obesity, Diabetes & Metabolism & action, Diabetes associated diseases, Diabetes medication and therapy, Diabetes market and Business analysis.
This Euro Diabetes 2024 invites all the Academic Scientists, Leading Endocrinologists, Surgeons, Primary Health care specialists, Paediatricians, Pharmaceutical Industrial Delegates, talented young scientists, and student communities across the globe where all the aspects of Diabetes Mechanism, Disorders, & Treatment will be discussed under single roof.
Young Research’s Awards at Euro Diabetes 2023 for the Nomination: Young Researcher Forum-Outstanding Masters/PhD/Post Doctorate thesis work Presentation, only 25 presentations acceptable at the Euro Diabetes 2023 conference young research forum.
- Young Scientist Award recognition certificate and memento to the winners
- Our conferences provide best Platform for your research through oral presentations.
- Learn about career improvement with all the latest technologies by networking.
- Young Scientists will get appropriate and timely information by this Forum.
- Platform for collaboration among young researchers for better development.
- Provide an opportunity for research interaction and established senior investigators across the globe in the field.
- Share the ideas with both eminent researchers and mentors.
It’s a great privilege for young researchers to learn about the research areas for expanding their research knowledge.
About Hosting Organization: Conference Series LLC Ltd
Conference Series LLC Ltd is the world’s leading specialist in organizing Academic, Scientific and Business conferences, meetings, symposiums and exhibitions in different verticals and horizontals like Medical, Pharma, Engineering, Science, Technology and Business to promote scientific research. Every year we host more than 3000+ global events inclusive of 1000+ Conferences 1000+ Symposiums 1000+ Workshops in USA, Europe, Middle East and Asia with the generous support and cooperation from our 30000+ Editorial Board Members, 1000+ Scientific Societies. All the conference proceedings are published in the special issues of our 700+ Open Access International Journals with the DOI provided by CROSSREF.
Sessions & Tracks
Diabetes is also a typical chronic sickness that imposes right sensible demands on the individual tending system. Individuals with genetic disorder have subsequent rate of disorder than those whereas not diabetes and are at increased risk for kidney disease, lower limb amputation and visual defect. Novel remedial targets accessible for polygenic disease incorporates Incretion based totally treatments, oral useful operators like secretagogues, cell recovery and enlargement and foundational organism treatments. Undeveloped Embryonic cell and fetal antecedent cell transplantation treatments are the significant undifferentiated cell treatments accessible for Diabetes. Aside from the on top of, different computational methodologies in Diabetes administration control have been presented as of late which are assuming an imperative part in recognizable proof of qualities delivery regarding diabetes serving to in Early Detection of polygenic disease. These procedures are likewise valuable in concentrating on the compound diagnostician of polygenic disorder revealing fully completely different treatment prospects and model development forms for survival expectation. The global diabetes research market is projected to reach USD $10.58 billion by 2022 from an estimated USD $8.35 billion in 2017, at a CAGR of 4.8% during the forecast period.
Track 2: Diabetes Mellitus Type 1
Diabetes mellitus type 1 (otherwise called type 1 diabetes) is a type of diabetes mellitus that outcomes from the immune system annihilation of the insulin-delivering beta cells in the pancreas. The ensuing absence of hypoglycaemic agent prompts expanded aldohexose within the blood and pee. The established manifestations are regular pee, expanded thirst, expanded yearning, and weight reduction. The reason for diabetes type one is obscure. Type 1 diabetes is recognized from kind two from antibody testing. The C-peptide test, which measures endogenous insulin generation, can likewise be utilized. Organization of insulin is fundamental for survival. Insulin treatment must be proceeded with uncertainly and commonly does not disable ordinary every day exercises. Individuals are usually ready to freely take care of their diabetes; be that because it could, for a few these will challenge. Untreated, diabetes can bring about numerous confusions. Intense confusions incorporate diabetic ketoacidosis and non-ketotic hyperosmolar trance like state. Genuine end of the day complexities known with high glucose incorporate coronary unwellness, stroke, kidney disappointment, foot ulcers and harm to the eyes. Moreover, confusions could emerge from low aldohexose caused by extortionate hypoglycemic agent treatment. Diabetes mellitus type 1 represents around five-hitter and 100% of all diabetes cases.
Track 3: Diabetes Mellitus Type 2
Type 2 diabetes may be a long-term metabolic turmoil that's pictured by high aldohexose, insulin resistance, and relative absence of insulin. Basic aspect effects incorporate expanded thirst, incessant pee, and unexplained weight reduction. Indications could likewise incorporate swollen desire, feeling tired, and bruises that don't recuperate. Regularly indications go ahead gradually. Long haul complexities from high aldohexose incorporate coronary malady, strokes, diabetic retinopathy which can bring about visual impairment, kidney disappointment, and poor blood stream in the appendages which may prompt removals. The sudden onset of hyperosmolar hyperglycaemic state may happen; in any case, diabetic ketoacidosis is unprecedented. Type 2 diabetes is mostly preventable by staying a typical weight, practicing consistently, and eating legitimately. Treatment includes activity and dietary changes. In the event that aldohexose levels aren't sufficiently brought down, the medicine metformin is regularly suggested. Numerous individuals may in the end likewise require insulin infusions. In that on insulin, routinely check glucose levels is exhorted, in any case this may not be required in those taking pills. Bariatric surgery of times enhances diabetes within the people UN agency ar stout. Diabetes mellitus may be a devastating and sophisticated metabolic malady, expected to affect over 500 million people worldwide by the year 2030; up from 350 million in 2010. Approximately 95% of patients suffer from type 2 diabetes, and its prevalence is expected to increase in the future.
Track 4: Diabetic Disorders & Treatment
Diabetes, frequently referred to by specialists as diabetes mellitus, depicts a gathering of diabetes and metabolic sicknesses in which the individual has high blood (glucose), either in light of the fact that hypoglycemic agent generation is lacking, or on the grounds that the body's phones don't react appropriately to insulin, or both. Patients with high glucose will normally encounter polyuria (continuous pee); they will turn out to be progressively parched (polydipsia) and hungry (polyphagia). Recognizing type 1 and type 2 diabetes at determination is critical. Average qualities of type 2 diabetes incorporate the, Slow and guileful onset, most normal in overweight or fat patients from a minority bunch (Native Americans, blacks, and Pacific Islanders), Signs of hypoglycemic agent resistance, strong family history of type 2 diabetes. Familial way of life danger components prompting heftiness might be available, as may a family history of cardiovascular disease or metabolic disorder. Paediatric Diabetes is a type 1 diabetes mellitus requires insulin treatment. The number of people living with diabetes in Europe is expected to increase from 52 million in 2014 to 68.9 million by 2035, according to the International Diabetes Federation (IDF). Across Europe, around 1 in 11 adults is affected and this number is set to rise as the population ages.
The concept of 'new innovations' for type 1 diabetes and new revelation and propelled type 2 diabetes treatment has extended as these days at a rate that some should seriously think about similar to 'Moore's Law', and the sheer number of new advancements going into the type 1 diabetes commercial centre is likewise developing at a surprising rate. From the patient's viewpoint, this is energizing as well as can prompt a feeling of positive thinking. Advancements that today are developing typical (e.g. insulin pumps, quick HbA1c observant, and so forth go under new remedial instruments of diabetes. Without a doubt, it might be contended that the real advances in type 1 diabetes care created within the last quarter of a century have originated from innovation rather than science. In the meanwhile, not all new innovations succeed (e.g. the Glucowatch), paying very little respect to their implied guarantee. Both type 1 diabetes patients and their healthful services suppliers can presently see a progression of additional propelled therapeutic advancements used as a section of doctor's facility and new innovations and novel treatments in diabetes treatment whose premise is fixing to the concept of enhancing the lives of these with the malady. The Asia-Pacific Diabetes Care Devices Market has been estimated at USD $2.461 Billion in 2015 and is projected to reach USD $3.518 billion by 2021, at a CAGR of 7.41% throughout the forecast amount from 2015 to 2021.
Track 6: Gestational Diabetes
Gestational diabetes is first analysed amid pregnancy. Like type 1 and type 2 diabetes, gestational diabetes causes glucose levels to wind up noticeably too high. When you eat, your stomach related framework separates the greater part of the sustenance into a sugar called glucose. It's the purpose at which the blood sugar level (glucose level) of the mother goes too high amid pregnancy. Gestational diabetes creates when your body can't deliver enough of the hormone insulin amid pregnancy. Insulin is very important to move aldohexose what your body utilizes for vitality into the cells. Without enough insulin, you can develop excessively glucose in your blood, prompting a higher-than-typical blood glucose level and maybe gestational diabetes. The higher blood glucose level in gestational diabetes caused by hormones discharged by the placenta amid pregnancy. The placenta delivers a hormone called the Human Placental Lactogen (HPL), otherwise called Human Chorionic Somatomammotropic (HCS). According to the International diabetes Federation in 2016, it absolutely was estimated that 420 million adult populations is laid low with diabetes that is increasing at the speed of 8.4% and is expected to reach 625 million by 2040. According to the American Pregnancy Association, approximately 2-5% of pregnant women develop gestational diabetes; this number may increase to 7-9% of mothers who are more likely to have risk factors.
Track 7: Stem Cell Treatment in Diabetes
Stem cells use in islet cell transplants to cure type 1 diabetes, stem cell replacement should be more than just an instance of swapping insulin-delivering cells from a healthy pancreas with those annihilated by diabetes in a diabetic patient. It is conceivable to treat Type 1 diabetes by transplanting confined islet cells, containing beta cells or even an entire pancreas into the patient from a contributor. Transplants will empower the body to recover management of aldohexose levels therefore administrating hypoglycaemic agent is rarely once more needed. Pancreatic stem cell islets, additionally called islets of Langerhans, are modest groups of cells scattered all through the pancreas. Pancreatic islets contain a few types of cells, including beta cells that create the hormone insulin. Insulin permits cells at some stage in the body to retain aldohexose from the circulation system and utilize it for vitality.
The global stem cell market is expected to reach USD $15.63 billion by 2025, growing at a CAGR of 9.2%, according to a new report by Grand View Research, Inc. Augmentation in analysis studies that aim at broadening the utility scope of associated merchandise is anticipated to drive the market growth. These analysis comes have opened the chance of implementation of many clinical applications of those cells, thereby impacting disease-modifying treatments.
Track 8: Diabetes Ophthalmology
Diabetic retinopathy is that the most typical diabetic disease and a number one explanation for visual impairment in adults within the U.S. It is caused by changes within the blood vessels of the membrane. The membrane is that the sensitive tissue at the rear of the attention. A healthy retina is necessary for good vision. Diabetic retinopathy is detected throughout an expanded eye communicating by associate degree specialist or specialist. A communicating by your primary doctor, during whom your eyes are not dilated, is not an adequate substitute for a full exam done by an ophthalmologist. Eye exams for individuals with polygenic disorder will include: sight testing. Diabetic retinopathy affects blood vessels within the sensitive tissue known as the membrane that lines the rear of the attention. It is the foremost common explanation for vision loss among individuals with polygenic disorder and therefore the leading explanation for vision impairment and visual impairment among working-age adults.
Diabetes can harm your eyes. It will harm the little blood vessels in your membrane, or the back of your eye. This condition is called diabetic retinopathy. Diabetes conjointly will increase your risk of eye disease and alternative eye issues. There is no cure for diabetic retinopathy. But optical device treatment surgical procedure is typically terribly effective at preventing vision loss if it's done before the membrane has been severely broken. Surgical removal of the vitreous gel (vitrectomy) may additionally facilitate improve vision if the membrane has not been severely broken. Diabetic Retinopathy Market was valued at $966 million in 2015, and is expected to reach $2,490 million by 2022, supported by a CAGR of 14.4% during the forecast period 2014 to 2022.
The Endocrine system controls the stream of information among cells and tissues, represented by complex managerial parts. Hormones apply in all cases impacts on various metabolic methods which ensure regulatory, change genic and integrative limit. Signs and indications of endocrine issue navigate the complete clinical range. The Endocrine system is a system of organs that create and discharge hormones that assistance controls numerous imperative body capacities, including the body's capacity to change calories into energy that forces cells and organs. The Endocrine system impacts how your heart beats, how your bones and tissues develop, even your capacity to make a child. It assumes a key half in despite whether or not you produce diabetes, thyroid illness, development issue, sexual brokenness, and a large group of other hormone-related disorders. Endocrine disease that outcomes once an organ delivers overly or deficient of an endocrine hormone, called a hormone imbalance. Endocrine disease is because of the improvement of injuries, (for example, knobs or tumours) in the endocrine system, which might influence hormone levels. Endocrine disorders may well be symptomless or sufficiently mild to not need treatment. Surgery or radiation treatment might be utilized. Regularly, finding and treatment of the hidden reason for the endocrine issue can resolve the symptoms.
Thyroid issues are not uncommon in youngsters, but rather they are not as regular as guardians. Hyperthyroidism and hyperactive thyroid organ is seen just the once in a while in new-borns. This condition is alluded to as neonatal hyperthyroidism. Although thyroid ailment happens less much of the time in kids than in grown-ups, the signs and indications can be comparable. In any case, there are a couple of essential contrasts that should be conveyed to light. Inborn hypothyroidism is a confusion that influences New-born children during childbirth, and happens in around 1 in 4000 live-conceived babies. It is delineated by the loss of thyroid capability, because of the thyroid organ neglecting to grow regularly. At times, the organ is totally absent. Around 10% of cases are brought on by a catalyst deformity prompting inadequate hormones generation, iodine lack and a cerebrum pituitary organ variation from the norm. On the off chance that the determination is postponed, and quick treatment is not given, innate hypothyroidism can prompt development and formative imperfections, and serious mental impediment (cretinism).
The global thyroid disorders treatment market is probably going to exhibit a 3.1% CAGR between 2015 and 2023. The market is expected to be worth US $2,414.6 mn by the end 2023 from a valuation of US $1,806.2 mn in 2014.
Track 11: Advances in Endocrinology Metabolism
Treat patients with hyperparathyroidism, Address particular issues of Graves' disease including thyrocardiac ailment, ophthalmopathy, dermopathy, delayed pregnancy, mammary, Use the 2015 ATA rules in the administration of their patients with thyroid knobs and thyroid malignancy determination, Determine when to do atomic hereditary disease testing amid assessment of a thyroid knob, Identify the ordinarily experienced adrenal and pituitary issue (clinical cases), Counsel patients on ripeness issues while being dealt with for growth, Provide the best treatment for transgender patients, Use the new lipid bringing operators and how down to oversee quiet who can't take statins. Intrinsic adrenal hyperplasia are any of a few autosomal latent sicknesses coming about because of changes of qualities for catalysts intervening the biochemical strides of creation of mineralocorticoids, glucocorticoids or sex steroids from cholesterol by the endocrine organs (steroid beginning).
Endocrine organs, they are the hormones creating organs in the body, and the regular ones are thyroid, parathyroid hormones, pancreas and adrenal organs. On the off probability that the thyroid endocrinology is making additional prohormones, a patient will have manifestations like uneasiness, tremors, sweating, palpitations, or trouble nodding off. At first, this is made do with prescription, or there are pills like radioactive iodine that can wreck the thyroid organ. Endocrine disruptors are chemicals that, at specific measurements, can meddle with the endocrine (or hormone) framework in warm blooded animals. These interruptions can bring about carcinogenic mind tumors, birth abscond, and other formative issue. Addison's sickness (likewise Addison infection, incessant adrenal deficiency, hypocortisolism, and hypoadrenalism) is an uncommon, never-ending endocrine framework issue in which the adrenal organs do not produce adequate steroid hormones (glucocorticoids and mineralocorticoids).
Track 13: Ketogenic Diet for Diabetes
A Ketogenic diet may be a very low-carb diet, considered to be once you eat a level of sugar of around 30 g of carbohydrates per day or below. This encourages the body to induce its energy from burning body fat that produces AN energy supply called ketones. The diet helps to lower the body's demand for hypoglycaemic agent that has advantages for individuals with type one and type II diabetes. Note that it's necessary that you just speak to your doctor if you're considering following the diet as precautions might have to be taken before beginning. On a Ketogenic diet, blood sugar levels area unit unbroken at a low however healthy level which encourages the body to interrupt down fat into a fuel supply called ketones. The method of breaking down or ‘burning’ body fat is known as ketosis. People on hypoglycemic agent can generally need smaller doses of hypoglycemic agent that results in less risk of huge dosing errors. The diet helps burn body fat and therefore, has specific benefits for those trying to reduce weight, as well as people with prediabetes, or those otherwise, in danger of type II diabetes.
The term diabetes describes many diseases of abnormal super molecule metabolism that square measure characterized by hyperglycaemia. It’s related to a relative or absolute impairment in endocrine secretion, at the side of varied degrees of peripheral resistance to the action of endocrine. They’re derived once doing several clinical trials on animal models. each few years, the Diabetes community revaluates the present recommendations for the classification, diagnosis, and screening of Diabetes, reflective new info from analysis and clinical apply that in turns facilitate in understanding current interference and treatment choices and value effectiveness in treatment and interference of Diabetes. Folks with type 1 Associate in nursing type 2 Diabetes have an exaggerated risk of developing variety of great health issues.
Systematically high blood sugar levels will result in serious diseases poignant the Macro tube-shaped structure and small tube-shaped structure complications. Additionally, folks with Diabetes even have a better risk of developing infections. In the majority high-income countries, Diabetes could be a leading reason behind disorder, blindness, nephritis, and lower limb amputation. Maintaining blood sugar levels, force per unit area, and cholesterol at or near traditional will facilitate delay or stop Diabetes complications. Hypoglycaemia Associate in nursing hyperglycaemia square measure the opposite 2 factors square measure the 2 major complications of Diabetes wherever hyperglycaemia is Associate in nursing acute complication sharing several symptoms and hypoglycaemia is an acute complication of many Diabetes treatments. Glycosylated haemoglobin could be a variety of haemoglobin that's measured primarily to spot the common plasma aldohexose concentration over prolonged periods of your time.
Track 14: Diabetes Research
Diabetes may be a common chronic illness that imposes right smart demands on the individual tending system. Individuals with polygenic disease have the next rate of disorder than those while not diabetes and are at multiplied risk for renal disorder, lower limb amputation and vision defect. Fleshiness may be an important risk issue for diabetes and also the prevalence of fleshiness in youngsters and adults has dramatically multiplied within the past four decades. Diabetic dyslipidemia is one among the foremost risk factors for disorder in diabetes. The characteristic options of diabetic dyslipidemia are a high plasma lipid concentration, low cholesterol concentration and multiplied concentration of tiny dense LDL-cholesterol particles. So as analysis to analyze the bioinformatics tools and methodologies accustomed in polygenic disease research, at first, this was tough to try and do as a result of it failed to have a preconceived notion concerning however the analysis would be organized and the way bioinformatics tools would be delineated or known within the analysis. To urge started, we tend to ran many perfunctory searches exploitation basic search terms like bioinformatics and diabetes (research) through many databases to examine what varieties of articles were came. Incapacity is outlined as a metabolic dysfunction that ranges from delicate glucose imbalance to full-fledged kind a type 2 diabetes. A bolus dose is internal secretion that's specifically taken at meal times to stay glucose levels in check following a meal.
Track 15: Insulin Medication
Insulin medical care is usually recommended for patients with kind a pair of diabetes associate degree an initial A1C level bigger than 9%, or if diabetes is uncontrolled despite optimum oral glycemic medical care. Internal secretion medical care is also initiated as augmentation, beginning at 0.3 units per weight unit, or as replacement, beginning at 0.6 to 1.0 units per weight unit. Aldohexose management, adverse effects, cost, adherence, and quality of life have to be compelled to be thought of once selecting medical care. Anti- diabetic drug ought to be continued if potential as a result of its verified to scale back all-cause mortality and vessel events in overweight patients with diabetes diseases. Volumetric analysis of internal secretion over time is important to up glycemic management and preventing diabetes-related complications.
Track 16: Case Reports and Others
Lipid disorders are a group of medical conditions which refer to excessive levels of fatty substances in the bloodstream. These fatty substances include cholesterol and triglycerides. An excess of bad cholesterol increases your risk of heart disease and stroke. A paraganglioma is rare neuroendocrine neoplasm that may develop at various body sites (including the head, neck, thorax and abdomen). About 97% are benign and cured by surgical removal; the remaining 3% are malignant neoplasm because they are able to produce distant metastases. "Paraganglioma" is now the most-widely accepted term for these lesions that have been also described as: Glomus tumor, chemodectoma, perithelioma, fibroangioma, and congenital nevi. Metabolic disorders of bone strength, usually caused by abnormalities of minerals (such as calcium or phosphorus), vitamin D, bone mass or bone structure. The most common metabolic bone disorder is osteoporosis.
“33rd European Diabetes Congress” is going to be held during February 08-09, 2024 Paris, France. The Conference will be organized around the theme “Empowering Lives: Managing Diabetes Together” highlighting the latest and exciting innovations in Diabetes Disease& Treatment. Euro Diabetes 2024 Conference invites all Academic Scientists, Leading Endocrinologists, Surgeons, Oncologists, Radiation Therapists, General Physicians, Dieticians, Primary Health care specialists, Internists, Pharmaceutical Industrial Delegates, talented young scientists, and student communities across the globe to attend European Diabetes conference under a single roof where networking and global partnering happens for the acceleration of future research.
Today’s Market Study of Diabetes in USA | Europe | Middle East | Asia Pacific
Europe: The number of people living with diabetes in Europe is expected to increase from 52 million in 2014 to 68.9 million by 2035, according to the International Diabetes Federation (IDF). Across Europe, around 1 in 11 adults is affected and this number is set to rise as the population ages.
USA: Diabetes Mellitus has been growing at an exponential rate and World Health Organization (WHO) estimates that the diabetic population is likely to reach 366 million in 2030. The United States is expected to have an increase of 102 per cent in the diabetic epidemic in 2030 when compared to 2000.
Middle East: The rate of diabetes in parts of the Arabian Peninsula is over twice the global average rate, and much higher than some other areas of the Middle East and North Africa (MENA). And cases of type-2 diabetes outnumber cases of type-1 diabetes by a ratio of 10:1.
Asia Pacific: The Asia-Pacific Diabetes Care Devices Market has been estimated at USD 2.461 Billion in 2015 and is projected to reach USD $3.518 billion by 2020, at a CAGR of 7.41% during the forecast period from 2015 to 2020.
Diabetes is one of the fastest growing health challenges of the 21st century, with the number of adults living with diabetes having more than tripled over the past 20 years. In 2000, the global estimate of adults living with diabetes was 151 million. By 2009 it had grown by 88% to 285 million. Today, we calculate that 9.3% of adults aged 20–79 years–a staggering 463 million people–are living with diabetes. A further 1.1 million children and adolescents under the age of 20 live with type 1 diabetes. A decade ago, in 2010, the global projection for diabetes in 2025 was 438 million. With over five years still to go, that prediction has already been surpassed by 25 million will be 578 million adults with diabetes by 2030, and 700 million by 2045.
Type 1 diabetes is caused by an autoimmune reaction in which the body’s immune system attacks the insulin-producing beta cells of the pancreas. As a result, the body produces very little or no insulin.
Type 2 diabetes is the most common type of diabetes. Initially, hyperglycaemia (high blood glucose levels) is the result of the inability of the body’s cells to respond fully to insulin, a situation termed ‘insulin resistance’.
Gestational diabetes (GDM) is characterized by high blood glucose levels during pregnancy. It may occur at any time during pregnancy. Women who experience GDM face an increased risk of developing type 2 diabetes later in life. In addition, babies born to mothers with GDM also have a higher lifetime risk of obesity and developing type 2 diabetes themselves. This contributes to an intergenerational cycle of obesity and diabetes that seriously impacts the health of the entire population, and the generations to come.
Impaired Glucose Tolerance (IGT) is a condition of raised blood glucose levels above the normal range, but below the recommended diabetes diagnostic threshold. The terms ‘prediabetes’ and ‘non-diabetic hyperglycaemia’ are sometimes used as alternatives.
IGT is important because it:
- Indicates a risk of developing type 2 diabetes in the future;
- Denotes an already heightened risk of cardiovascular diseases;
- Offers the opportunity for interventions that can lead to the prevention of type 2 diabetes.
The estimated number of adults with IGT, and therefore at increased risk of developing type 2 diabetes, is 374 million. It is predicted to rise to 454 million by 2030 and to 548 million by 2045.
Insulin: Launch of generic versions of insulin and extensively growing demand for novel insulin in controlling the blood sugar levels in both type 1 and type 2 diabetes ate factors anticipated to fuel the growth of insulin segment in the market during the forecast period. In March 2019 Eli Lilly (key player) and company launched Lispro, a generic version of rapid-acting Humalog insulin which shall be available in the US by making it more accessible for diabetic patients. Additionally, growing investments in research and development by many government organizations and new product launches by many key players are like to boost the diabetes drugs market growth during the forecast period. For example, in 2019 Glenmark launched an oral anti-diabetic drug Remogliflozin in India which is considered as an effective drug treating adults with type-2 diabetes mellitus.
Growing urbanization and changing lifestyle habits (e.g. higher calorie intake, increasing consumption of processed foods, sedentary lifestyles) are contributory factors for the increasing prevalence of type 2 diabetes at a societal level. While global prevalence of diabetes in urban areas is 10.8%, in rural areas it is lower, at 7.2%. However, this gap is closing, with rural prevalence on the rise.
Diabetes increases the risk of early death: Approximately 4.2 million adults will die as a result of diabetes and its complications in 2019. This is equivalent to one death every eight seconds. Globally, 11.3% of deaths are due to diabetes. Almost half of these deaths are in people under 60 years of age. Half of the 463 million adults living with diabetes today are unaware that they have the condition, and are therefore at high risk of developing serious diabetes related complications.
Economic and social impact: Annual global health expenditure on diabetes is estimated to be at USD 760 billion under direct costs. It is projected that these direct costs will reach USD 825 billion by 2030 and USD 845 billion by 2045. The costs of treating complications account for over 50% of the direct health costs of diabetes. For example, management of diabetic ketoacidosis (DKA) is a considerable part of the cost to a country’s health system: treatment of a single DKA episode in the United Kingdom costs an estimated GBP 1,387 (around USD 1,750).
Age profile of diabetes
Working age (20-64) 72.0% three in four people living with diabetes (352 million people) are of working age (between 20 and 64 years old). This number is expected to increase to 417 million by 2030 and to 486 million by 2045.
Older people (65+) 27.8% in 2019, the estimated number of people over 65 years of age with diabetes is 111 million. One in five adults in this age group is estimated to have diabetes. It is projected that by 2030 the number of people over 65 with diabetes will further increase to 195 million. By 2045, it will reach 276 million.
Children and adolescents (0–19) 0.2% an estimated 1.1 million children and adolescents (aged under 20) have type 1 diabetes. There is some evidence that type 2 diabetes among children and adolescents is increasing in some countries.
Age adjusted comparisons - Prevalence of diabetes in adults (20-79 years)
South & Central America
Middle East & North Africa
North America & Caribbean
Countries with the highest numbers of people with diabetes (2019): In 2019, the countries with the largest numbers of adults with diabetes are China, India and the United States of America, and are anticipated to remain so until 2030. It is projected that the number of people with diabetes in Pakistan will exceed that in the United States of America by 2045, moving the country to third place.
No. of people with diabetes (millions)
Low- and middle-income countries: The highest prevalence of diabetes in adults occurs in high-income countries, with an estimated 10.4% of the population having diabetes. The diabetes prevalence is 4% in low-income countries, and 9.5% in middle-income countries.
Improved education at the population-level, strong health systems, and effective policy frameworks are key to adequately address the primary risk factors of type 2 diabetes (such as poor eating habits, obesity and inadequate physical activity) and the high numbers of people living with undiagnosed diabetes.
Societies Associated with Diabetes Research:
Past Conference Content
32nd European Diabetes Congress was organized during February 22-23, 2023, Webinar. The conference was marked with the attendance of Editorial Board Members of supporting journals, Scientists, young and brilliant researchers, business delegates and talented student communities, who made this conference fruitful and productive.
This conference was based on the theme “Diabetes: A view through the scope” which included the following scientific tracks:
- Diabetes Research in Clinical Practice
- Diabetes Mellitus Type 1
- Diabetes Mellitus Type 2
- Diabetic Disorders & Treatment
- Diabetes Advanced Technologies
- Insulin Medication
- Gestational Diabetes
- Stem Cell Treatment in Diabetes
- Diabetes Ophthalmology
- Ketogenic Diet for Diabetes
- Thyroid Disorders in Children, Teens and Adolescents
- Endocrinology Diabetes Diseases Disorders
- Advances in Endocrinology Metabolism
- Treatment & Diagnosis of Endocrine Diseases
- Diabetes Research
Conference Series LLC Ltd has taken the privilege of felicitating Euro Diabetes 2023 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this conference.
The esteemed guests, keynote speakers and researchers shared their innovative research and vast experience through their informative presentations at the podium of Euro Diabetes 2023. We are glad to inform that all accepted abstracts for the conference have been published in Journal of Diabetic Complications & Medicine: Open Access as a special issue.
Conference Series LLC Ltd is glad to announce its “33rd European Diabetes Congress” during February 19-20, 2024 in London, UK. We cordially welcome all the eminent researchers, professionals in the field of nutrition to discuss latest research and challenges in the field Euro Diabetes 2024. is designed to provide an exclusive platform for clinical nutritionists, registered dieticians, and other health-care professionals, researchers and students working in the field to deliberately, exchange views and their experiences in front of a large international audience, students and delegates to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Euro Diabetes with 20% abatement on the Early Bird Prices.
Bookmark your dates for “Euro Diabetes 2024” as the Nominations for Best Poster Awards and Young Researcher Awards are open across the world.
Attending the 33rd European Diabetes Congress is a fantastic opportunity for anybody interested in the field of prevention of diabetes and complications to acquire new knowledge, get new skills, and network with other experts from across the world.
Here are some reasons why you should attend:
- Learn about the latest research and advancements in diabetes medicine: The conference will feature presentations and discussions by experts in the field, providing attendees with the latest information on research and advancements.
- Gain new skills and knowledge: Attendees will have the opportunity to attend workshops and sessions on a range of topics related to diabetes medicine, providing them with new skills and knowledge that they can apply in their work.
- Connect with other professionals: The conference will bring together researchers, clinicians, policymakers, and industry leaders from around the world, providing attendees with the opportunity to connect with others who share their interests and expertise.
- Network with potential collaborators: The conference provides a platform for attendees to meet potential collaborators and build relationships that can lead to future collaborations and partnerships.
- Share your own work: Attendees can submit their own research or case studies for presentation at the conference, providing an opportunity to share their work with others in the field and receive valuable feedback.
- Explore Amsterdam: The conference will be held in Amsterdam, Netherlands, providing attendees with the opportunity to explore this beautiful city and its culture, history, and cuisine.
Attending the 34th International Conference on Diabetes can be a valuable experience for anyone interested in the field of prevention of diabetes and complications, whether you are a researcher, clinician, policymaker, or industry professional.
Benefits of Participation
Advantages of Participating at our Conference
- The Speaker and Abstract pages that Google creates on your profile under your name would give you global visibility.
- Our Library of Abstracts receives more than 30,000 visits per month and 50 thousand views, which brings scholars and speakers to our Conference.
- Meet and exchange ideas with thousands of thought leaders in obesity and nutritional health.
- Each conference attendee would have a different motivation for engaging in one-on-one discussions with distinguished speakers and recognized keynote speakers.
- At our Keynote presentations, you'll have the exceptional chance to hear what the world's foremost authorities on obesity are discovering.
Benefits of Participation for Speaker
- Admiration for researchers' profile on a global scale.
- Obtain points for your professional development.
- Discover the most recent cutting-edge analysis.
- Become lifelong friends through social and networking activities.
- An opportunity to promote one page through the distribution of abstract books and flyers, which eventually receives 1 million views and greatly enhances your research profile.
- Learn about new topics and studies that are unrelated to your primary subject of obesity and nutritional health by making a transition outside of your field of interest.
- We've combined exceptional networking, education, and fun into one bundle.
Benefits of Participation for Delegate
- Increased knowledge and understanding for professional development.
- Attending webinars helps participants feel refreshed and energized.
- Your participation in our conference will support the development of a new approach and philosophy that can be used to improve business or industry results.
Benefit of Participation for Sponsor
- The likelihood of new businesses would rise with exposure to the global marketplace.
- A chance to showcase your business's most cutting-edge innovations, fresh products, or services to a large international audience.
- Lead generation will help our webinar participants do more business.
- To draw energy from others who have a similar purpose and objective, it's always helpful to have a network of co-workers and associates. Building a successful firm takes a lot of time, effort, and drive.
- Webinars on obesity offer chances for greater thought and reflection, which might help you advance your business.
- comparing the major organization's plans and advancing them.
- Get answers to your company's queries and difficulties at our conference from reliable people.
Benefit of Association for Collaborators
- No other website has this many visits, making Obesity the finest platform for bringing attention to society.
- establishing enduring peer ties.
- Your organization's logo, branding and marketing materials, promotional content, and the webinar banner will all work together to add 40% more subscribers and members to your list.
- Your association will be greatly impacted by the visibility of our event to your company's placement in the Global Business forum.
- Your representatives can interact with important delegates to update their knowledge and comprehension of your organization and services.
- Information will be incorporated into obesity advertising materials such posters, brochures, pamphlets, and services that will be distributed to hospitals, universities, the general public, and researcher.
Diabetes Research Universities:
Heinrich Heine University | Charite University | Humboldt University | Ludwig Maximilian University | Technical University of Munich | University of Hamburg | University of Wurzburg | Maastricht University | German Diabetes Center Mergentheim
German Diabetes Association | European Thyroid Association | European Neuroendocrine Association | European Foundation for the Study of Diabetes | Central European Diabetes Association | FAND - Italian Association of Diabetics |Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy | American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association |American Association for Clinical Endocrinology | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria |Diabetes Association of the Republic of China | Asian Diabetic Association
German Society of Endocrinology | German Society for Internal Medicine | Czech Diabetes Society |Pediatric Endocrine Society | International Society of Endocrinology | European Society of Endocrinology | Diabetes Canada Australian Diabetes Society | Diabetes Technology Society | Australian Diabetes Society | The Japan Diabetes Society | Diabetic Society of Singapore | Joint British Diabetes Societies | IDS Immunology Of Diabetes Society | International Society for Pediatric and Adolescent Diabetes | Endocrine Society Of India | Irish Endocrine Society